CDH17 and neoplasm: A comprehensive analysis was conducted on the Gene Expression Profiling and Interactive Analyses (GEPIA) database to identify antigens as potentially suitable tumor-associated targets for developing BsADCs with CDH17, which should also be highly expressed in colorectal cancer.